World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
36636
World Ranking
10779
National Ranking
5544

Overview

Javid Moslehi is affiliated with the University of California, San Francisco in the United States. Their research broadly spans the field of Medicine, with a focus on Oncology and Cardiology and Cardiovascular Medicine, as well as Molecular Biology, Immunology, and Genetics.

Their recent scholarly contributions include papers published between 2020 and 2022 in notable journals. These include:

  • 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS), 2022, European Heart Journal
  • Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations, 2020, Annals of Oncology
  • Immune-checkpoint inhibitors: long-term implications of toxicity, 2022, Nature Reviews Clinical Oncology
  • Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy, 2020, Circulation Heart Failure
  • Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society, 2020, European Journal of Heart Failure

Their frequent co-authors include Joe-Elie Salem, Stéphane Éderhy, Douglas B. Johnson, Juan Qin, and Lorenz Lehmann, reflecting a collaborative network in both oncology and cardiology research.

Javid Moslehi's work has been published extensively in several venues, with the highest numbers of publications in:

  • Circulation (22 publications)
  • Circulation Research (12 publications)
  • European Heart Journal (9 publications)
  • Journal of Clinical Oncology (8 publications)
  • JACC CardioOncology (7 publications)

Their main fields of study total 426 publications, with subfields distributed as 152 in Oncology, 107 in Cardiology and Cardiovascular Medicine, 31 in Molecular Biology, 29 in Immunology, and 25 in Genetics.

The primary topics researched by Moslehi include:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Viral Infections and Immunology Research
  • Chronic Lymphocytic Leukemia Research
  • Peptidase Inhibition and Analysis
  • Cardiac Imaging and Diagnostics

Best Publications

  • Fulminant Myocarditis with Combination Immune Checkpoint Blockade

    Douglas B. Johnson;Justin M. Balko;Margaret L. Compton;Spyridon Chalkias

  • Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

    Daniel Y. Wang;Joe Elie Salem;Joe Elie Salem;Justine V. Cohen;Sunandana Chandra

  • Declining NAD + Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging

    Ana P. Gomes;Ana P. Gomes;Nathan L. Price;Alvin J.Y. Ling;Javid Moslehi

  • Telomere dysfunction induces metabolic and mitochondrial compromise

    Ergiin Sahin;Simona Colla;Marc Liesa;Javid Moslehi

  • MYOCARDITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS

    Syed S. Mahmood;Michael G. Fradley;Justine V. Cohen;Anju Nohria

  • Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline

    Saro H. Armenian;Saro H. Armenian;Christina Lacchetti;Ana Barac;Joseph Carver

  • Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.

    Joe-Elie Salem;Joe-Elie Salem;Ali Manouchehri;Melissa Moey;Bénédicte Lebrun-Vignes

  • Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

    Giuseppe Curigliano;Daniel J. Lenihan;Michael G. Fradley;Sarju Ganatra

  • Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

    Javid J. Moslehi;Joe Elie Salem;Jeffrey A. Sosman;Bénédicte Lebrun-Vignes

  • Cardiovascular Toxic Effects of Targeted Cancer Therapies

    Javid J. Moslehi

  • Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society

    Alexander R. Lyon;Susan Dent;Susannah Stanway;Helena Earl

  • Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.

    Enrico Ammirati;Maria Frigerio;Eric D. Adler;Cristina Basso

  • Immune checkpoint inhibitors and cardiovascular toxicity.

    Alexander R Lyon;Nadia Yousaf;Nicolò M L Battisti;Javid Moslehi

  • Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement from the American Heart Association

    Robb D. Kociol;Leslie T. Cooper;James C. Fang;Javid J. Moslehi

  • Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia

    Javid J. Moslehi;Michael Deininger

  • Cardiovascular toxicities associated with immune checkpoint inhibitors.

    Jiun Ruey Hu;Roberta Florido;Evan J. Lipson;Jarushka Naidoo

  • Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.

    Joe-Elie Salem;Yves Allenbach;Aurore Vozy;Nicolas Brechot

  • High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells

    Arun Sharma;Paul W. Burridge;Paul W. Burridge;Wesley L. McKeithan;Wesley L. McKeithan;Ricardo Serrano

  • Roles of interferon-gamma and interleukin-4 in murine lupus

    S L Peng;J Moslehi;J Craft

  • Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology

    Marc P. Bonaca;Benjamin A. Olenchock;Joe Elie Salem;Stephen D. Wiviott

Frequent Co-Authors

Douglas B. Johnson
Douglas B. Johnson Vanderbilt University Medical Center
William G. Kaelin
William G. Kaelin Harvard University
Dan M. Roden
Dan M. Roden Vanderbilt University Medical Center
Christian Funck-Brentano
Christian Funck-Brentano Université Paris Cité
Lee W. Jones
Lee W. Jones Memorial Sloan Kettering Cancer Center
Justin M. Balko
Justin M. Balko Vanderbilt University Medical Center
Phyllis C. Zee
Phyllis C. Zee Northwestern University
Wendy Demark-Wahnefried
Wendy Demark-Wahnefried University of Alabama at Birmingham
Susan Cheng
Susan Cheng Cedars-Sinai Medical Center
Jose G. Montoya
Jose G. Montoya Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in healthcare careers beyond traditional medical school, there are numerous flexible academic options available online. Many students start their journey with online nursing programs, which offer a variety of entry points for those seeking a rewarding patient care role. These programs can be more affordable and accessible, especially for those balancing work and study.

For those looking to advance their qualifications, affordable graduate programs have become increasingly popular. Options such as the cheapest dnp programs are ideal for nurses aiming for leadership or specialized positions. Similarly, registered nurses seeking further advancement often choose the cheapest accredited online rn to bsn programs to expand their career potential and earning power.

For those holding a non-nursing bachelor’s degree, direct-entry routes like direct msn programs online can provide a fast track into advanced nursing roles. These online degrees offer flexibility, affordability, and a pathway to diverse healthcare careers, whether you’re starting out or advancing within the medical field.

Best Scientists Citing Javid Moslehi

Trending Scientists

Recently Published Articles